Trial NCT04145115

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-07242
Secondary IDs: A071702 NCI-2019-07242 U10CA180821

Last trial update was posted on 2024-04-18

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Astrocytoma Glioblastoma Glioma

Other Conditions

Astrocytoma, IDH-Mutant, Grade 4 Diffuse Glioma Glioblastoma, IDH-Wildtype Secondary Glioblastoma

Stopping Reasons

Other - Evaluating accrual and study design

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID